Related to Scientists Claim Leukemia Stem Cell Signature Independently Predicts Poor Survival in AML

• Geron to Develop Human ESC-Derived Chondrocytes for Cartilage Repair
  
• ISCO and Insight Bioventures Sets Up Indian Affiliate
  
• ACEA and Vivo Partner to Develop Stem and Cancer Cell Assays for xCELLigence Platform
  
• Scientists Pinpoint Gene that Regulates Stem Cell Apoptosis
  
• Cellectis Negotiates License to Kyoto University iPSC IP for Research Use and Therapeutics
  
• New Voltage-Sensitive Cell Type Directs Stem-Cell Daughters to Trigger Cancer
  
• Cellectis and the Center for iPS Cells Research and Application Join Forces
  
• UCB and Plasticell Partner to Identify Compounds for SC Research and Cell Therapeutics
  
• EpiCept to Secure Almost $2M via Registered Direct Financing
  
• First Patient Receives ReNeuron’s Neural Stem Cell Therapy
  
• Stem Cell Environment Created that Provides Chemical, Electrical, and Mechanical Cues
  
• Clavis Raises €19M to Progress Pipeline Based on Lipid Vector Technology
  
• Investigators Find New Method to Create Mesenchymal-Like Stem Cells
  
• Scientists Use Bone Marrow MSCs for Partial Bladder Regeneration in Primates
  
• Plasticell and Sigma-Aldrich Partner on Stem Cell Differentiation Tools
  
• CIRM Gains Access to Five of BioTime’s ESC Lines
  
• Shrink and EV Group Partner to Develop and Manufacture Nanotech StemDisc Products
  
• Antisoma Drops AML Candidate after Disappointment in Phase III
  
• Scientists Generate Alzheimer-Relevant Neurons from hESCs and iPSCs
  
• Cell Therapeutics Pays Chroma $5M Up Front for Rights to Late-Stage Cancer Drug